Florian Then Bergh

Leipzig University of Applied Sciences — Germany

Medicine · Health Sciences

43h-index8.0kcitations185works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(89), Peripheral Neuropathies and Disorders(37), Autoimmune Neurological Disorders and Treatments(15), Stress Responses and Cortisol(14), Polyomavirus and related diseases(12)

Publications174 total

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany
Frontiers in Neurology·2025Open Access
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis
Neurology Neuroimmunology & Neuroinflammation·2025Open Access
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis
Neurology Neuroimmunology & Neuroinflammation·2025· 1 citedOpen Access
2500P Treatment intensification in the metastatic castration-sensitive prostate cancer landscape: real-world evidence from 4,559 patients in the CAPRI-3 registry
Annals of Oncology·2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis
EBioMedicine·2025· 1 citedOpen Access
Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)– a database analysis
BMC Neurology·2025· 1 citedOpen Access
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)
BMJ Neurology Open·2025· 1 citedOpen Access
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
Frontiers in Immunology·2025· 4 citedOpen Access
Escalation Treatment with Methylprednisolone Versus Immunoadsorption in MS Relapse: Results of the EMMA Trial (P11-1.011)
Neurology·2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2
Journal of Neurology·2025· 6 citedOpen Access
Effect of impairment on health-related quality of life in people with multiple sclerosis: association of functional systems and EQ-5D-5L index values in a cross-sectional study
Quality of Life Research·2025Open Access
Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases
Therapeutic Advances in Neurological Disorders·2025Open Access
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD
Journal of Neurology Neurosurgery & Psychiatry·2024· 15 citedOpen Access
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision
Journal of Neurology·2024· 3 citedOpen Access
Adult Neuropsychiatric Manifestation of Hartnup Disease With a Novel <i>SLCA6A19</i> Variant
Neurology Genetics·2024· 2 citedOpen Access
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
Journal of Neurology Neurosurgery & Psychiatry·2024· 14 citedOpen Access
Mineralocorticoid Receptor Signaling in Peripheral Blood Cells in Patients with Multiple Sclerosis
International Journal of Molecular Sciences·2024Open Access
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)
Journal of Neurology Neurosurgery & Psychiatry·2024· 11 citedOpen Access
Cognitive performance in adults with post-COVID syndrome: Results from a German case-control study
Journal of Psychiatric Research·2024· 3 citedOpen Access
Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study
Advances in Therapy·2024· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Friedemann Paul(25), Brigitte Wildemann(21), Tania Kümpfel(21), Uwe K. Zettl(17), Bernhard Hemmer(16), Martin Stangel(16), Ralf Gold(14), Ralf A. Linker(14), Achim Berthele(13), Corinna Trebst(13), Antonios Bayas(13), Marius Ringelstein(12), Hayrettin Tumani(12), Luisa Klotz(12), Christian Geis(11), Ulf Ziemann(11), Heinz Wiendl(11), Björn Tackenberg(11), Klemens Ruprecht(10), Kerstin Hellwig(10)